1. Short-Wave Infrared Emitting Nanocomposites for Fluorescence-Guided Surgery
- Author
-
Mark C. Pierce, Shuqing He, Prabhas V. Moghe, Jake N. Siebert, Richard E. Riman, Amber Gonda, Mei Chee Tan, Carolina Bobadilla Mendez, Xinyu Zhao, Jay V. Shah, and Vidya Ganapathy
- Subjects
medicine.medical_specialty ,Nanocomposite ,Materials science ,media_common.quotation_subject ,Fluorescence ,Article ,Atomic and Molecular Physics, and Optics ,Surgery ,chemistry.chemical_compound ,Fluorescence intensity ,Animal model ,chemistry ,Ambient lighting ,medicine ,Short wave infrared ,Contrast (vision) ,Electrical and Electronic Engineering ,Indocyanine green ,media_common - Abstract
Fluorescence-guided surgery (FGS) is an emerging technique for tissue visualization during surgical procedures. Structures of interest are labeled with exogenous probes whose fluorescent emissions are acquired and viewed in real-time with optical imaging systems. This study investigated rare-earth-doped albumin-encapsulated nanocomposites (REANCs) as short-wave infrared emitting contrast agents for FGS. Experiments were conducted using an animal model of 4T1 breast cancer. The signal-to-background ratio (SBR) obtained with REANCs was compared to values obtained using indocyanine green (ICG), a near-infrared dye used in clinical practice. Prior to resection, the SBR for tumors following intratumoral administration of REANCs was significantly higher than for tumors injected with ICG. Following FGS, evaluation of fluorescence intensity levels in excised tumors and at the surgical bed demonstrated higher contrast between tissues at these sites with REANC contrast than ICG. REANCs also demonstrated excellent photostability over 2 hours of continuous illumination, as well as the ability to perform FGS under ambient lighting, establishing these nanocomposites as a promising contrast agent for FGS applications.
- Published
- 2021
- Full Text
- View/download PDF